Kneat: Streamlining Compliance in Life Sciences
Kneat is redefining how life sciences companies handle regulatory compliance, one digital document at a time.
Digital validation software gains traction across major pharmaceutical giants
In an industry where every step must be documented and regulatory compliance is non-negotiable, Kneat is helping life sciences companies reduce costs and improve accuracy. Their digital validation platform has become the go-to choice for eight of the ten largest pharmaceutical companies worldwide. With customers like Merck rolling out Kneat across 27 global sites and over 12,000 users, the company is scaling rapidly. Offering a significant reduction in cycle time, documentation labor, and compliance errors, Kneat has seen its revenue climb 32% year-over-year in 2025. And with market penetration still low, the $2B total addressable market for digital validation remains largely untapped.
To learn more about Kneat.com, Inc. (TSX: KSI, OTC: KSIOF), watch their video HERE
Published by BTV - The Agency
Discover Investment Opportunities with BTV. Delivering engaging content to Investors for 25+ years.
